In a recent study, we have investigated the expression of CXCR4, together with those of its ligand CXCL12, in primary NSCLC specimens of patients with and without brain metastasis, using a quantitative double-labeling immunofluorescence analysis [70]. The gene discussed is CXCL12; the disease is non-small cell lung carcinoma.